SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
10-May-24 4:04 PM View: | Holles Natalie C. CEO Director | Third Harmonic Bio, Inc. (THRD) | 09-May-24 | Option Exercise | 20,222 | $4.20 | $84,932.40 | 2% 1.22M to 1.24M | |
10-May-24 4:04 PM View: | Holles Natalie C. CEO Director | Third Harmonic Bio, Inc. (THRD) | 09-May-24 | Planned Option Sale | 20,222 | $12.18 | $246,300.00 | (2%) 1.24M to 1.22M | |
15-Apr-24 4:14 PM View: | Holles Natalie C. CEO Director | Third Harmonic Bio, Inc. (THRD) | 11-Apr-24 | Planned Option Sale | 13,558 | $12.19 | $165,214.00 | (1%) 1.23M to 1.22M | |
15-Apr-24 4:14 PM View: | Holles Natalie C. CEO Director | Third Harmonic Bio, Inc. (THRD) | 11-Apr-24 | Option Exercise | 13,558 | $4.20 | $56,943.60 | 1% 1.22M to 1.23M | |
08-Apr-24 5:21 PM View: | Person Julie Chief Administrative Officer | Third Harmonic Bio, Inc. (THRD) | 04-Apr-24 | Option Exercise | 1,107 | $4.20 | $4,649.40 | 100% 0 to 1.11K | |
08-Apr-24 5:21 PM View: | Person Julie Chief Administrative Officer | Third Harmonic Bio, Inc. (THRD) | 04-Apr-24 | Planned Option Sale | 1,107 | $10.00 | $11,070.00 | (100%) 1.11K to 0 | |
07-Dec-23 4:03 PM View: | Conner Edward R. Chief Medical Officer | Third Harmonic Bio, Inc. (THRD) | 05-Dec-23 | Planned Option Sale | 4,790 | $10.03 | $48,062.40 | (100%) 4.79K to 0 | |
07-Dec-23 4:04 PM View: | Person Julie Chief Administrative Officer | Third Harmonic Bio, Inc. (THRD) | 05-Dec-23 | Option Exercise | 12,863 | $4.20 | $54,024.60 | 100% 0 to 12.86K | |
07-Dec-23 4:03 PM View: | Conner Edward R. Chief Medical Officer | Third Harmonic Bio, Inc. (THRD) | 05-Dec-23 | Option Exercise | 4,790 | $4.20 | $20,118.00 | 100% 0 to 4.79K | |
07-Dec-23 4:04 PM View: | Person Julie Chief Administrative Officer | Third Harmonic Bio, Inc. (THRD) | 05-Dec-23 | Planned Option Sale | 12,863 | $10.30 | $132,484.00 | (100%) 12.86K to 0 | |
22-Dec-22 6:49 PM View: | Bvf Partners L P/il 10% Owner | Third Harmonic Bio, Inc. (THRD) | 20-Dec-22 | Private Purchase | 214,063 | $4.11 | $879,499.00 | 5% 4.12M to 4.34M | |
19-Sep-22 4:51 PM View: | Atlas Venture Fund Xi, L.P. 10% Owner | Third Harmonic Bio, Inc. (THRD) | 19-Sep-22 | Conversion | 7,066,470 | -- | -- | 200% 3.54M to 10.61M | |
21-Sep-22 5:59 PM View: | Bonita David P Director 10% Owner | Third Harmonic Bio, Inc. (THRD) | 19-Sep-22 | Market Purchase Duplicate | 300,000 | $17.00 | $5,100,000.00 | 5% 5.48M to 5.78M | |
19-Sep-22 4:51 PM View: | Atlas Venture Fund Xi, L.P. 10% Owner | Third Harmonic Bio, Inc. (THRD) | 19-Sep-22 | Market Purchase | 300,000 | $17.00 | $5,100,000.00 | 3% 10.61M to 10.91M | |
21-Sep-22 6:00 PM View: | Orbimed Advisors LLC Director 10% Owner | Third Harmonic Bio, Inc. (THRD) | 19-Sep-22 | Conversion Duplicate | 5,479,070 | -- | -- | 100% 0 to 5.48M | |
21-Sep-22 5:59 PM View: | Bonita David P Director 10% Owner | Third Harmonic Bio, Inc. (THRD) | 19-Sep-22 | Conversion | 5,479,070 | -- | -- | 100% 0 to 5.48M | |
21-Sep-22 6:00 PM View: | Orbimed Advisors LLC Director 10% Owner | Third Harmonic Bio, Inc. (THRD) | 19-Sep-22 | Market Purchase Duplicate | 300,000 | $17.00 | $5,100,000.00 | 5% 5.48M to 5.78M |